跳到正文
原文
Medical Xpress·· 2026-10-03AI 评分33

丹麦Aarhus University研究:新生儿足跟血可测量抗group B Streptococcus抗体,或助力孕妇疫苗开发

Heel-prick blood samples from newborns could provide important insights into protection against serious infection

AI 导读

丹麦Aarhus University团队在The Lancet Microbe发表概念验证横断面研究,发现新生儿常规足跟血干血斑样本可测量母体经胎盘转移的抗group B Streptococcus(GBS)IgG抗体,其水平与标准血样高度一致。研究人员正扩大样本量并探索保护性抗体阈值,长期或为孕妇GBS疫苗开发提供评估工具。

正文
newborn foot
Credit: Pixabay/CC0 Public Domain

Heel-prick blood samples from newborns can be used to measure antibodies against group B Streptococcus, according to a new study from Aarhus University published in The Lancet Microbe journal. In the longer term, the method could contribute to the development of vaccines designed to protect infants against serious infections.

A few days after birth, all newborns in Denmark have a small blood sample taken from their heel. Among other purposes, the sample is used to screen babies for a wide range of rare congenital diseases.

A new study shows that these blood samples can also be used to measure how many antibodies against group B Streptococcus, also known as GBS, a baby has received from its mother during pregnancy.

GBS can cause serious infections in newborns, which is why researchers are working to identify ways of protecting infants against the bacterium. One possible approach is to vaccinate the mother during pregnancy, so her immune system produces antibodies against GBS.

These antibodies can be transferred from mother to baby before birth and may therefore help protect the newborn. By making it possible to measure how many antibodies babies receive from their mothers, the new study represents an important step toward improving protection for infants, says May Murra, a postdoctoral researcher at the Department of Biomedicine at Aarhus University:

"To improve our ability to protect newborns against serious GBS infections, we need to know how effectively mothers can transfer antibodies to their babies before birth. We can now gain that knowledge, having shown that the heel-prick samples already collected from newborns can be used to measure antibody levels," she explains.

The researchers compared measurements of GBS antibodies from heel-prick samples and umbilical cord blood with measurements from a standard blood sample taken from the same newborn.

The results show that measurements from heel-prick samples closely reflect the level of GBS antibodies found in standard blood samples. Umbilical cord blood also generally provided a good indication of the baby's antibody level.

"Heel-prick samples appear to be a practical and reliable way of measuring these antibodies. A major advantage is that the samples are already collected routinely, and the material is easier to collect, store and transport than standard blood samples," says Murra.

Could contribute to the development of a vaccine for pregnant women

In the short term, the findings are particularly relevant to researchers and vaccine developers working on group B Streptococcus vaccines for pregnant women.

The researchers have already begun investigating the relationship between the amount of GBS antibodies in a baby and the risk of developing an infection. The aim is to determine what level of antibodies is required to protect a newborn.

If it becomes possible to identify an antibody level associated with protection, this could potentially be used to assess the effectiveness of future vaccines.

"In the longer term, we hope this knowledge can help pave the way for a vaccine for pregnant women that can protect newborns against serious GBS infections. First, however, we need to learn more about what level of antibodies actually protects the baby," says Murra.

The study is a small proof-of-concept study. This means that the researchers have primarily investigated whether the method works in principle. The research team is therefore now working to expand the study using a larger group of blood samples from different populations and countries.

Publication details

May Murra et al, Assessment of dried blood spot and umbilical cord blood samples for the quantification of maternally transferred IgG against the group B streptococcal alpha-like surface proteins in neonates at Kolding Hospital, Denmark: a proof-of-concept, cross-sectional study, The Lancet Microbe (2026). DOI: 10.1016/j.lanmic.2026.101409

Journal information: The Lancet Microbe

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Heel-prick blood samples from newborns could provide important insights into protection against serious infection (2026, October 2) retrieved 2 October 2026 from https://medicalxpress.com/news/2026-10-heel-blood-samples-newborns-important.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com